RECURSION PHARMACEUTICALS, INC. (RXRX) Free cash flow 2019–2025
RECURSION PHARMACEUTICALS, INC. (RXRX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$378.3MFY2025 · since FY2019: -$61.0M → -$378.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$378.3M | -1.5% |
| FY2024 | -$372.9M | -24.4% |
| FY2023 | -$299.7M | -148.6% |
| FY2022 | -$120.6M | +39.2% |
| FY2021 | -$198.4M | -287.3% |
| FY2020 | -$51.2M | +16.0% |
| FY2019 | -$61.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice